Evidence map›Paper›PMID 18687466›Full record

ReviewPlacenta2008

The functional role of the renin-angiotensin system in pregnancy and preeclampsia.

R A Irani, Y Xia

Open access · greenAbstract readReview
In one paragraph

Review in Placenta, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 6 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 6 syntheses or guidelines pooled it, 283 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2012
    Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Article
  10. Hypertensive Disorders of Pregnancy and Primary Aldosteronism.Hypertension (Dallas, Tex. : 1979) · 2026
    Article
  11. Hypertensive Disorders of Pregnancy and Primary Aldosteronism.medRxiv : the preprint server for health sciences · 2026
    Article
  12. Article
  13. Review
  14. Localization and quantification of placentalPhysiological genomics · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R A IraniUniversity of Texas - Houston Health Science Center, Department of Biochemistry and Molecular Biology, 6431 Fannin Street, MSB 6.200, Houston, TX 77030, USA.
Y Xia
The University of Texas Health Science Center at Houston · US

Funding

AT1 Receptor Activating Autoantibodies and PreeclampsiaR01HL076558 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIA, YANG · 2005 to 2008
$1.0M
NHLBI NIH HHS R01 HL076558
6 · The paper itself

Abstract

During normal pregnancy, the renin-angiotensin system (RAS) plays a vitally important role in salt balance and subsequent well-being of mother and fetus. In this balance, one must consider not only the classical renal RAS but also that of the uteroplacental unit, where both maternal and fetal tissues contribute to the signaling cascade. Many studies have shown that in normal pregnancy there is an increase in almost all of the components of the RAS. In derangements of pregnancy this delicate equilibrium can become unbalanced. Preeclampsia is one such case. It is a disorder of pregnancy characterized by hypertension, proteinuria and placental abnormalities associated with shallow trophoblast invasion and impaired spiral artery remodeling. Despite being a leading cause of maternal death and a major contributor to maternal and perinatal morbidity, the mechanisms responsible for the pathogenesis of preeclampsia are poorly understood. Immunological mechanisms and the RAS have been long considered to be involved in the development of preeclampsia. Numerous recent studies demonstrate the presence of the angiotensin II type I receptor agonistic autoantibody (AT1-AA). This autoantibody can induce many key features of the disorder and upregulate molecules involved in the pathogenesis of preeclampsia. Here we review the functional role of the RAS during pregnancy and the impact of AT1-AA on preeclampsia.

Indexed as

Angiotensin IIAnimalsAutoantibodiesCalciumDisease Models, AnimalFemaleHumansPeptidyl-Dipeptidase APlacentaPlacenta DiseasesPlasminogen Activator Inhibitor 1Pre-EclampsiaPregnancyReactive Oxygen SpeciesRenin-Angiotensin SystemThromboplastinAngiotensin IIAutoantibodiesCalciumFLT1 protein, humanPeptidyl-Dipeptidase APlasminogen Activator Inhibitor 1Reactive Oxygen SpeciesThromboplastinVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID18687466
PMCPMC2614866
OpenAlexW1993234733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.